BANK OF MONTREAL /CAN/ - ACER THERAPEUTICS INC ownership

ACER THERAPEUTICS INC's ticker is ACER and the CUSIP is 00444P108. A total of 31 filers reported holding ACER THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of ACER THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$5,000
-28.6%
1,331
-68.6%
0.00%
Q1 2020$7,000
-87.5%
4,233
-69.5%
0.00%
Q4 2019$56,000
-24.3%
13,870
-40.1%
0.00%
Q3 2019$74,000
+236.4%
23,141
+327.0%
0.00%
Q2 2019$22,000
-71.8%
5,419
+68.8%
0.00%
Q1 2019$78,000
+21.9%
3,2100.0%0.00%
Q4 2018$64,000
+30.6%
3,210
+100.0%
0.00%
Q3 2018$49,0001,6050.00%
Other shareholders
ACER THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 147,000$3,572,0001.70%
Vivo Capital, LLC 579,051$14,071,0001.40%
Nantahala Capital Management 884,455$21,492,0000.67%
HEARTLAND ADVISORS INC 220,000$5,346,0000.40%
DRIEHAUS CAPITAL MANAGEMENT LLC 387,632$9,419,0000.35%
EMERALD MUTUAL FUND ADVISERS TRUST 125,000$3,038,0000.12%
SPHERA FUNDS MANAGEMENT LTD. 50,000$1,215,0000.11%
ARDSLEY ADVISORY PARTNERS LP 18,000$437,0000.08%
683 Capital Management, LLC 19,367$471,0000.04%
Tibra Equities Europe Ltd 12,232$297,0000.03%
View complete list of ACER THERAPEUTICS INC shareholders